Kingston Chronic Obstructive Pulmonary Disease (COPD) Multidimensional Long Term Follow up Cohort

Launched by DR. JUAN PABLO DE TORRES TAJES · Dec 12, 2019

Keywords

ClinConnect Summary

The Kingston COPD Multidimensional Long Term Follow Up Cohort is a clinical trial designed to better understand and manage Chronic Obstructive Pulmonary Disease (COPD), a condition that makes it hard to breathe. This study aims to gather detailed information about patients over a long period, which will help doctors, medical students, and researchers improve treatments and care for COPD patients. Participants will undergo various tests, including lung function tests and a walking test, to track their health and responses to treatment.

To be eligible for the trial, you need to be between 40 and 85 years old, have a history of smoking, and have been diagnosed with COPD. If you are interested in participating, you should also be able to complete the required tests and provide consent. The study is currently recruiting participants, and your involvement could contribute to important research that helps many people with COPD in the future. If you have any questions or want to know more about the study, feel free to reach out to the team overseeing the trial.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Patients ages between 40-85 years old.
• • 2. Smoking history of at least 10 pack year history
• • 3. Active of former smokers
• • 4. Diagnosis of COPD according to the GOLD definition (4): post bronchodilator spirometry FEV1/FVC ≤0.70, including those with other associated respiratory diseases like asthma, bronchiectasis, stable lung cancer or Interstitial Lung Disease.
• • 5. Ability to perform all study procedures (complete pulmonary function tests, six minute walking test (6MWT) and chest computed tomography) and provide/sign informed consent.
• Exclusion Criteria:
• • 1. Patients not willing to sign the consent form
• • 2. Patients with a life expectancy of less than 3 yrs.
• • 3. Patients in palliative care.
• • 4. Patients with chronic airway obstruction ie: FEV1/FVC≤0.70 of other etiology and without a smoking history of less than 10 packs year history.
• • 5. Patients unable ort not able to perform the pulmonary function test, the 6MWT or the chest CT.